1'758 companies found
Insmed Switzerland GmbH
Zug · Since 2019
Insmed Corporation focuses on the development and commercialization of drugs for rare and serious diseases, particularly in the areas of respiratory diseases and rare diseases. The core activities include research and development of new drugs, the acquisition and licensing of clinical and commercial assets, the conduct of clinical trials, and the commercialization of drugs in the US, Europe, Japan, and other regions.
inventuri development sàrl
St-Prex · Since 2020
The core activity of Inventuri is to support customers in the development of pharmaceutical projects, particularly in the areas of research and development, intellectual property, competitive analysis, and life sciences. This includes: Research and Development: Accelerating the transition from research to early development stages up to Proof of Concept; Intellectual Property: Supporting the securing of ideas through prior art searches, freedom-to-operate analysis, and patent claims; Competitive Analysis: Conducting competitive analyses and landscape analyses in the technical field; Life Sciences: Supporting the development of pharmaceutical projects, including medicinal chemistry and organic synthesis.
In Virtuo Laboratories SA
Lugano · Since 2024
In Virtuo Laboratories SA develops a platform that combines artificial intelligence and physics-based molecular simulations to identify and optimize drug candidates.
iOnctura SA
Geneva · Since 2017
The core activity of iOnctura is the development of cancer drugs, particularly in oncology immunotherapy, with a focus on solid tumors, uveal melanoma and other types of cancer.
Iovance Biotherapeutics GmbH
Zug · Since 2017
Iovance Biotherapeutics GmbH develops and investigates tumor‑infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors. The company conducts preclinical and clinical research on T‑cell‑based immunotherapies, operates manufacturing capabilities and maintains a clinical pipeline and products shown on the website such as AMTAGVI (lifileucel) and Proleukin (aldesleukin).
IPSEN Pharma Schweiz GmbH
Zug · Since 2019
The core activity of Ipsen is the development and provision of innovative pharmaceutical products for people with rare or severe diseases, particularly in the therapeutic areas of oncology, neurology and rare diseases.
IREMIS Therapeutics SA
Anières · Since 2024
IREMIS Therapeutics SA develops therapeutic and theranostic solutions for neuropathic and other chronic pain conditions using a personalized medicine approach. The company is advancing its lead molecule IRX-001 (NDMC) in Phase II clinical development and applies pharmacogenetics, evidence‑based dosing guidance and patient monitoring to optimize treatment.
Isanas AG
Arosa · Since 2014
The core activity of Isanas AG is the development of new therapies for severe inflammatory diseases, such as multiple sclerosis, arthritis, asthma and others.
Isomorphic Labs Switzerland AG
Zurich · Since 2023
Isomorphic Labs Switzerland AG develops AI-based technologies to accelerate drug discovery and development. The company operates a unified drug‑design engine using predictive and generative models to run in‑silico experiments, participates in research collaborations with pharmaceutical companies, and advances an internal pipeline focused on oncology and immunology.
ITNOA Pharmaceuticals GmbH
St. Gallen · Since 2024
ITNOA Pharmaceuticals GmbH distributes pharmaceutical products and supplies medicines to healthcare providers and partners. The company states it works with manufacturers and healthcare partners to provide medicines that meet safety and effectiveness standards.
Janssen-Cilag AG
Zug · Since 1979
Janssen-Cilag AG develops and commercializes pharmaceutical medicines and therapies in areas such as oncology, immunology, neuroscience and cardiopulmonary medicine.
Jantar GmbH
Horgen · Since 2015
The core activity of Jantar GmbH is the development of pharmaceutical products, particularly research and development (R&D) of medications for the treatment of rhinosinusitis, specifically with the active ingredient JT-1 for nasal spray application.
Jazz Pharmaceuticals Switzerland GmbH
Zug · Since 2021
Jazz Pharmaceuticals Switzerland GmbH is a biopharmaceutical company that develops and commercializes medicines. It focuses on treatments for patients with limited or no options, including therapies in rare disease, neuroscience (e.g., epilepsy) and oncology.
Jet Medical SA
La Chaux-De-Fonds · Since 1995
Jet Medical SA manufactures and supplies vascular access devices and catheters, including hemodialysis and plasmapheresis catheters, peritoneal dialysis catheters, PICC and port systems, and infusion lines.
KalVista Pharmaceuticals Switzerland GmbH
Zug · Since 2024
Kamfarma SA
Lugano · Since 1978
The core activity of Kamfarma is the development and manufacturing of pharmaceutical active ingredients (APIs) and finished dosage forms (FDFs) in cooperation with global marketing partners. The company specializes in the development of complex generics and innovative medicines, particularly in the areas of oncology and specialized medicines. Kamfarma offers services such as API development, manufacturing and project management, as well as the development of finished dosage forms in various formulations. In addition, the company supports its partners in the clinical development, registration and marketing of medicines in various territories.
KA Pharmaceuticals SA
Viganello · Since 2024
KA Pharmaceuticals SA provides Procurement-as-a-Service (PaaS) for pharmaceutical products and medical cannabis, integrating sourcing, compliance, logistics and delivery under a single accountable partner. The company serves pharmacies, wholesalers, brands and manufacturers with GMP/GDP release management, regulatory support, export readiness and market-entry services.
Kbiotech Gmbh
Mezzovico · Since 2021
The core activity of Isospec Analytics is the development and application of artificial intelligence (AI) supported IR-fingerprinting technology for the identification and analysis of molecules in biological samples. The company provides solutions for life sciences, diagnostics and research, aiming to decipher the complexity of biological samples and enable new insights in molecular biology.
KD Pharma Group SA
Bioggio · Since 2018
The core activity of KD Pharma Group is the development, manufacture and marketing of pharmaceutical active ingredients, dietary supplements and specialty chemicals, particularly in the areas of omega-3 fatty acids, cannabinoids and lipids. The company also offers services such as custom synthesis, laboratory analytics and packaging solutions.
KD Swiss GmbH
Zug · Since 2018
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register